Retention of endothelium-dependent properties in human mammary arteries after cryopreservation

Ann Thorac Surg. 1996 Feb;61(2):667-73. doi: 10.1016/0003-4975(95)01090-4.

Abstract

Background: We investigated the effects of cryopreservation and antibiotic treatment on endothelium-dependent vasomotor properties of human internal mammary arteries (IMAs).

Methods: Sixty IMA specimens from routine coronary artery bypass grafting procedures were randomly assigned to six groups. Group I (controls) were immediately tested after harvest. Remaining groups were prepared according to a stepwise design: group II, 6 hours of warm ischemia; group III, 6 hours of warm ischemia + 24 hours at 4 degrees C (without antibiotics); group IV, 6 hours of warm ischemia + 24 hours of 4 degrees C antibiotic disinfection; group V, 6 hours of warm ischemia + 24 hours at 4 degrees C (without antibiotics) + cryopreservation; and group VI, 6 hours of warm ischemia + 24 hours of 4 degrees C disinfection+cryopreservation. The IMA specimens were cut into rings and the tension of vascular smooth muscle was recorded. The IMA rings were contracted with norepinephrine (3 x 10(-6) mol/L) and tested with cumulative concentrations of acetylcholine (from 1 x 10(-9) to 1 x 10(-5) mol/L), contracted with endothelin-1 (from 1 x 10(-11) to 1 x 10(-6) mol/L), and contracted with the nitric oxide-synthase inhibitor NG-monomethyl-L-arginine (1 x 10(-4) mol/L). Rings were also tested for their capacity to generate 6-keto-prostaglandin F1 (the stable metabolite of prostacyclin), and endothelial cell viability rate was finally evaluated with the trypan blue dye exclusion method.

Results: Our results show that a complete cryopreservation protocol does not significantly modify (p > 0.05) the relaxant activity to acetylcholine in norepinephrine-precontracted IMA rings (controls; 90.2% +/- 4.2% vs group VI, 77.1% +/- 6.2%) or the vasoconstrictor response induced by endothelin-1 (controls, 62.6% +/- 2.8% versus group VI, 73.7% +/- 4.8%) and NG-monomethyl-L-arginine (controls, 22.4% +/- 1.5% versus group VI, 18.9% +/- 1.9%). Furthermore, IMA cryopreservation does not significantly modify (p > 0.05) the endothelial release of prostacyclin either in basal conditions (-20% versus controls) or during pharmacologic intervention with acetylcholine (-18% versus controls), endothelin-1 (-17% versus controls), and NG-monomethyl-L-arginine (-18% versus controls).

Conclusions: We conclude that the IMA endothelial function does not seem significantly injured by any of the current steps of disinfection and cryopreservation.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Acetylcholine / pharmacology
  • Analysis of Variance
  • Anti-Bacterial Agents / pharmacology
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Cryopreservation*
  • Dose-Response Relationship, Drug
  • Endothelins / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Humans
  • In Vitro Techniques
  • Mammary Arteries / drug effects
  • Mammary Arteries / physiopathology*
  • Muscle, Smooth, Vascular / drug effects
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Norepinephrine / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects
  • omega-N-Methylarginine

Substances

  • Anti-Bacterial Agents
  • Endothelins
  • Vasoconstrictor Agents
  • omega-N-Methylarginine
  • 6-Ketoprostaglandin F1 alpha
  • Arginine
  • Nitric Oxide Synthase
  • Acetylcholine
  • Norepinephrine